Outcome prediction for treatment of brain arteriovenous malformations: performance of endovascular predictive scores in a single-center population.

IF 4.5 1区 医学 Q1 NEUROIMAGING
Juan E Basilio Flores, Joel Aguilar-Melgar, Henry Pacheco-Fernandez Baca
{"title":"Outcome prediction for treatment of brain arteriovenous malformations: performance of endovascular predictive scores in a single-center population.","authors":"Juan E Basilio Flores, Joel Aguilar-Melgar, Henry Pacheco-Fernandez Baca","doi":"10.1136/jnis-2024-022927","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endovascular embolization is an accepted treatment modality for brain arteriovenous malformations (bAVM); however, treatment outcomes are highly variable, warranting accurate prediction for adequate patient selection. Several predictive scores have been proposed for this purpose. The objective of this study was to externally validate these scores for embolization of bAVM.</p><p><strong>Methods: </strong>This study involved bAVM patients treated with transarterial embolization. Endovascular predictive scores were identified through literature search. Relevant data for scoring of included patients was extracted. Primary study outcomes were radiological cure and neurological complications. The performance of the scores was evaluated by analyzing calibration (z-scores from logistic regression), discrimination (area under the receiver operating characteristic curve, AUROC), and classification (Youden's index and corresponding sensitivity and specificity). Additionally, sensitivity analyses were performed restricting the study population by size, location, and embolization intent.</p><p><strong>Results: </strong>A total of 198 bAVM (190 patients) were included. The rates of radiological cure and neurological complications were 18.2% and 14.1%, respectively. The literature search identified seven predictive scores. In the overall analysis, the Toronto score showed the best performance for radiological cure (AUROC 0.905). No significant difference was observed between the performance of the assessed scores for neurological complications. The sensitivity analysis showed improved performance of most scores. The Toronto score exhibited the highest performance for radiological cure (AUROC 0.857). The AVM Embolization Prognostic Risk Score (AVMEPRS) showed the highest performance for neurological complications (AUROC 0.751). The AVM Embocure Score (AVMES) showed fair to good performance for both efficacy and safety outcomes.</p><p><strong>Conclusion: </strong>Among the selected scores, the Toronto, AVMEPRS, and AVMES scores showed the best performances.</p>","PeriodicalId":16411,"journal":{"name":"Journal of NeuroInterventional Surgery","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of NeuroInterventional Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnis-2024-022927","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Endovascular embolization is an accepted treatment modality for brain arteriovenous malformations (bAVM); however, treatment outcomes are highly variable, warranting accurate prediction for adequate patient selection. Several predictive scores have been proposed for this purpose. The objective of this study was to externally validate these scores for embolization of bAVM.

Methods: This study involved bAVM patients treated with transarterial embolization. Endovascular predictive scores were identified through literature search. Relevant data for scoring of included patients was extracted. Primary study outcomes were radiological cure and neurological complications. The performance of the scores was evaluated by analyzing calibration (z-scores from logistic regression), discrimination (area under the receiver operating characteristic curve, AUROC), and classification (Youden's index and corresponding sensitivity and specificity). Additionally, sensitivity analyses were performed restricting the study population by size, location, and embolization intent.

Results: A total of 198 bAVM (190 patients) were included. The rates of radiological cure and neurological complications were 18.2% and 14.1%, respectively. The literature search identified seven predictive scores. In the overall analysis, the Toronto score showed the best performance for radiological cure (AUROC 0.905). No significant difference was observed between the performance of the assessed scores for neurological complications. The sensitivity analysis showed improved performance of most scores. The Toronto score exhibited the highest performance for radiological cure (AUROC 0.857). The AVM Embolization Prognostic Risk Score (AVMEPRS) showed the highest performance for neurological complications (AUROC 0.751). The AVM Embocure Score (AVMES) showed fair to good performance for both efficacy and safety outcomes.

Conclusion: Among the selected scores, the Toronto, AVMEPRS, and AVMES scores showed the best performances.

脑动静脉畸形治疗的预后预测:单中心人群血管内预测评分的表现。
背景:血管内栓塞是脑动静脉畸形(bAVM)的一种公认的治疗方式;然而,治疗结果是高度可变的,保证准确预测充分的患者选择。为此提出了几个预测分数。本研究的目的是从外部验证这些评分对bAVM栓塞的影响。方法:本研究纳入经动脉栓塞治疗的bAVM患者。通过文献检索确定血管内预测评分。提取纳入患者评分的相关数据。主要研究结果是放射治疗和神经系统并发症。通过分析校正(逻辑回归的z分数)、鉴别(受试者工作特征曲线下面积,AUROC)和分类(约登指数及其相应的敏感性和特异性)来评价评分的效果。此外,根据研究人群的大小、位置和栓塞意图进行敏感性分析。结果:共纳入bam 198例(190例)。放射学治愈率为18.2%,神经系统并发症率为14.1%。文献检索确定了七个预测分数。在整体分析中,多伦多评分显示放射治疗的最佳表现(AUROC为0.905)。在神经系统并发症的评估得分之间没有观察到显着差异。敏感性分析显示,大多数分数的表现都有所改善。多伦多评分显示放射治疗效果最高(AUROC为0.857)。AVM栓塞预后风险评分(AVMEPRS)显示神经系统并发症的表现最高(AUROC为0.751)。AVM栓塞评分(AVMES)在疗效和安全性方面都显示出相当好的表现。结论:在所选评分中,多伦多评分、AVMEPRS评分和AVMES评分表现最佳。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.50
自引率
14.60%
发文量
291
审稿时长
4-8 weeks
期刊介绍: The Journal of NeuroInterventional Surgery (JNIS) is a leading peer review journal for scientific research and literature pertaining to the field of neurointerventional surgery. The journal launch follows growing professional interest in neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumors, and spinal compression.The journal is owned by SNIS and is also the official journal of the Interventional Chapter of the Australian and New Zealand Society of Neuroradiology (ANZSNR), the Canadian Interventional Neuro Group, the Hong Kong Neurological Society (HKNS) and the Neuroradiological Society of Taiwan.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信